Medicenna Therapeutics Corp (MDNA) Cash Flow Statement

0.970
+0.050+5.43%

15min DelayMarket Closed Jan 22 16:00 ET

80.91MMarket Cap-5.71P/E (TTM)

Medicenna Therapeutics Corp (MDNA) Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Sep 30, 2025

(Q1)Jun 30, 2025

(FY)Mar 31, 2025

(Q4)Mar 31, 2025

(Q3)Dec 31, 2024

(Q2)Sep 30, 2024

(Q1)Jun 30, 2024

(FY)Mar 31, 2024

(Q4)Mar 31, 2024

(Q3)Dec 31, 2023

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

12.04%-4.94M

-52.32%-3.55M

-1.43%-16.49M

-3.12%-5M

11.70%-3.56M

-43.15%-5.61M

32.87%-2.33M

-28.47%-16.26M

-111.48%-4.85M

-10.09%-4.03M

Net income from continuing operations

-17.27%-4.88M

-35.50%-4.93M

53.64%-11.81M

108.54%1.19M

-4.30%-5.19M

-11.85%-4.16M

-27.08%-3.64M

-153.44%-25.47M

-260.58%-13.9M

-336.20%-4.98M

Operating gains losses

56.49%-429K

-423.61%-377K

-188.04%-7.25M

-164.01%-6.64M

515.07%449K

-2.71%-986K

94.26%-72K

257.48%8.24M

647.08%10.38M

102.12%73K

Depreciation and amortization

109.09%23K

280.00%19K

1,225.00%53K

1,800.00%19K

1,700.00%18K

1,000.00%11K

400.00%5K

0.00%4K

0.00%1K

Remuneration paid in stock

-28.66%468K

-9.93%390K

83.13%2.21M

1.85%496K

295.60%629K

145.69%656K

46.28%433K

-11.82%1.21M

151.03%487K

-53.24%159K

Other non cashItems

--6K

--7K

-3.35%-1.02M

---1.02M

--0

----

15.46%-984K

----

Change In working capital

89.22%-122K

42.42%1.34M

77.33%1.31M

217.15%963K

-24.79%540K

-343.44%-1.13M

148.16%943K

-69.25%741K

-180.35%-822K

18.09%718K

-Change in receivables

-108.62%-5K

657.34%1.22M

-112.46%-209K

-185.00%-289K

-56.04%240K

137.42%58K

-123.02%-218K

36.31%1.68M

60.38%340K

-1.80%546K

-Change in payables and accrued expense

90.17%-117K

-88.98%128K

262.54%1.52M

207.75%1.25M

74.42%300K

-291.94%-1.19M

304.76%1.16M

-179.47%-937K

-243.28%-1.16M

230.77%172K

Cash from discontinued investing activities

Operating cash flow

12.04%-4.94M

-52.32%-3.55M

-1.43%-16.49M

-3.12%-5M

11.70%-3.56M

-43.15%-5.61M

32.87%-2.33M

-28.47%-16.26M

-111.48%-4.85M

-10.09%-4.03M

Investing cash flow

Cash flow from continuing investing activities

-33K

-2K

-31K

Net PPE purchase and sale

--0

---33K

--0

---2K

---31K

--0

Cash from discontinued investing activities

Investing cash flow

--0

---33K

--0

---2K

---31K

--0

Financing cash flow

Cash flow from continuing financing activities

-102.69%-19K

-99.81%39K

23.49M

-19K

1.91M

706K

20.9M

Net issuance payments of debt

---19K

---13K

---19K

----

--0

----

Net common stock issuance

--0

--19.71M

--0

--19.71M

--0

Proceeds from stock option exercised by employees

--0

-95.60%52K

--3.8M

--0

--1.91M

--706K

--1.18M

--0

Cash from discontinued financing activities

Financing cash flow

-102.69%-19K

-99.81%39K

--23.49M

---19K

--1.91M

--706K

--20.9M

--0

Net cash flow

Beginning cash position

-42.58%20.46M

46.25%24.84M

-49.45%16.98M

37.86%30M

18.45%30.43M

20.31%35.63M

-49.45%16.98M

63.60%33.6M

-39.82%21.76M

-35.80%25.69M

Current changes in cash

-0.96%-4.96M

-118.92%-3.51M

142.85%6.97M

-3.51%-5.02M

59.09%-1.65M

-25.20%-4.91M

634.54%18.54M

-234.35%-16.26M

-95.36%-4.85M

-14.34%-4.03M

Effect of exchange rate changes

183.33%245K

-899.08%-871K

350.85%888K

-308.70%-144K

1,154.64%1.22M

-4,100.00%-294K

121.25%109K

-136.95%-354K

189.61%69K

128.96%97K

End cash Position

-48.24%15.75M

-42.58%20.46M

46.25%24.84M

37.86%30M

18.45%30.43M

20.31%35.63M

-49.45%16.98M

-39.82%21.76M

Free cash from

12.07%-4.94M

-50.32%-3.55M

-1.63%-16.53M

-3.12%-5M

11.70%-3.56M

-43.20%-5.62M

31.98%-2.36M

-28.47%-16.26M

-111.48%-4.85M

-10.09%-4.03M

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Sep 30, 2025	(Q1)Jun 30, 2025	(FY)Mar 31, 2025	(Q4)Mar 31, 2025	(Q3)Dec 31, 2024	(Q2)Sep 30, 2024	(Q1)Jun 30, 2024	(FY)Mar 31, 2024	(Q4)Mar 31, 2024	(Q3)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	12.04%-4.94M	-52.32%-3.55M	-1.43%-16.49M	-3.12%-5M	11.70%-3.56M	-43.15%-5.61M	32.87%-2.33M	-28.47%-16.26M	-111.48%-4.85M	-10.09%-4.03M
Net income from continuing operations	-17.27%-4.88M	-35.50%-4.93M	53.64%-11.81M	108.54%1.19M	-4.30%-5.19M	-11.85%-4.16M	-27.08%-3.64M	-153.44%-25.47M	-260.58%-13.9M	-336.20%-4.98M
Operating gains losses	56.49%-429K	-423.61%-377K	-188.04%-7.25M	-164.01%-6.64M	515.07%449K	-2.71%-986K	94.26%-72K	257.48%8.24M	647.08%10.38M	102.12%73K
Depreciation and amortization	109.09%23K	280.00%19K	1,225.00%53K	1,800.00%19K	1,700.00%18K	1,000.00%11K	400.00%5K	0.00%4K	0.00%1K	0.00%1K
Remuneration paid in stock	-28.66%468K	-9.93%390K	83.13%2.21M	1.85%496K	295.60%629K	145.69%656K	46.28%433K	-11.82%1.21M	151.03%487K	-53.24%159K
Other non cashItems	--6K	--7K	-3.35%-1.02M	---1.02M	--0	----	----	15.46%-984K	----	----
Change In working capital	89.22%-122K	42.42%1.34M	77.33%1.31M	217.15%963K	-24.79%540K	-343.44%-1.13M	148.16%943K	-69.25%741K	-180.35%-822K	18.09%718K
-Change in receivables	-108.62%-5K	657.34%1.22M	-112.46%-209K	-185.00%-289K	-56.04%240K	137.42%58K	-123.02%-218K	36.31%1.68M	60.38%340K	-1.80%546K
-Change in payables and accrued expense	90.17%-117K	-88.98%128K	262.54%1.52M	207.75%1.25M	74.42%300K	-291.94%-1.19M	304.76%1.16M	-179.47%-937K	-243.28%-1.16M	230.77%172K
Cash from discontinued investing activities
Operating cash flow	12.04%-4.94M	-52.32%-3.55M	-1.43%-16.49M	-3.12%-5M	11.70%-3.56M	-43.15%-5.61M	32.87%-2.33M	-28.47%-16.26M	-111.48%-4.85M	-10.09%-4.03M
Investing cash flow
Cash flow from continuing investing activities	0	0	-33K	0	0	-2K	-31K	0	0	0
Net PPE purchase and sale	--0	--0	---33K	--0	--0	---2K	---31K	--0	--0	--0
Cash from discontinued investing activities
Investing cash flow	--0	--0	---33K	--0	--0	---2K	---31K	--0	--0	--0
Financing cash flow
Cash flow from continuing financing activities	-102.69%-19K	-99.81%39K	23.49M	-19K	1.91M	706K	20.9M	0	0	0
Net issuance payments of debt	---19K	---13K	---19K	----	----	--0	--0	--0	----	----
Net common stock issuance	--0	--0	--19.71M	--0	--0	--0	--19.71M	--0	--0	--0
Proceeds from stock option exercised by employees	--0	-95.60%52K	--3.8M	--0	--1.91M	--706K	--1.18M	--0	--0	--0
Cash from discontinued financing activities
Financing cash flow	-102.69%-19K	-99.81%39K	--23.49M	---19K	--1.91M	--706K	--20.9M	--0	--0	--0
Net cash flow
Beginning cash position	-42.58%20.46M	46.25%24.84M	-49.45%16.98M	37.86%30M	18.45%30.43M	20.31%35.63M	-49.45%16.98M	63.60%33.6M	-39.82%21.76M	-35.80%25.69M
Current changes in cash	-0.96%-4.96M	-118.92%-3.51M	142.85%6.97M	-3.51%-5.02M	59.09%-1.65M	-25.20%-4.91M	634.54%18.54M	-234.35%-16.26M	-95.36%-4.85M	-14.34%-4.03M
Effect of exchange rate changes	183.33%245K	-899.08%-871K	350.85%888K	-308.70%-144K	1,154.64%1.22M	-4,100.00%-294K	121.25%109K	-136.95%-354K	189.61%69K	128.96%97K
End cash Position	-48.24%15.75M	-42.58%20.46M	46.25%24.84M	46.25%24.84M	37.86%30M	18.45%30.43M	20.31%35.63M	-49.45%16.98M	-49.45%16.98M	-39.82%21.76M
Free cash from	12.07%-4.94M	-50.32%-3.55M	-1.63%-16.53M	-3.12%-5M	11.70%-3.56M	-43.20%-5.62M	31.98%-2.36M	-28.47%-16.26M	-111.48%-4.85M	-10.09%-4.03M
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Amidst the global market turbulence triggered by the US-Europe dispute over Greenland, a single post by Trump instantly reversed market tren Show More

Futubull Options Sir

Jan 19 17:47

Options Weekly 0119 | Greenland tariff standoff, gold and silver surge again, shocking reversal in Fed chair nominee! Watch Intel, Netflix earnings reports

杨杨得億

Jan 20 13:42

The real danger in the 2026 market isn't black swan events, but rather the changes you've become accustomed to ignoring.